Indraprastha Medical Corporation Limited has informed the Exchange regarding Appointment of Mr Sudhir Jalan as Independent Director of the company w.e.f. August 06, 2025.
INDRAMEDCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indraprastha Medical Corporation (Indraprastha Apollo Hospitals) announced its Q1 FY26 results with revenue from operations rising to Rs 365.06 crore (vs Rs 347.86 crore in Q1 FY25) and profit after tax jumping to Rs 51.46 crore (vs Rs 44.77 crore), translating to an EPS of Rs 5.61. The Board appointed Mr. Sudhir Jalan, a former FICCI and AIMA president, as Independent Director for 5 years effective August 6, 2025, subject to shareholder approval. M/s Devarajan Swaminathan and Co. were re-appointed as Cost Auditors for FY 2025-26, and M/s RSM & Co. were appointed as Secretarial Auditors for a 5-year term (FY 2025-26 to FY 2029-30). The 37th AGM is scheduled for September 24, 2025, with the record date fixed as September 18, 2025 for determining dividend eligibility for FY 2024-25.
Strong Q1 results with ~15% YoY PAT growth and the fixation of a record date indicate a dividend is likely on the way. The director and auditor appointments are routine governance matters unlikely to materially affect the stock price.